NOTE: Although this activity is no longer certified for credit, we believe that it contains important information and hope you’ll review, print or email it to a colleague.
Practical Strategies to Improve Diabetes Care: A Case-Based Discussion of Patient-Centered Management
Diabetes, Diabetes / Endocrinology
1.00 AMA PRA Category 1 Credits
- Describe pathogenic mechanisms involved in the progression of type 2 diabetes
- Implement patient-specific and evidence-based strategies for achieving and maintaining glycemic control
- Empower patients with type 2 diabetes to employ self-management strategies within the context of a patient-centered team-based approach to care
- Implement culturally sensitive management strategies for patients with type 2 diabetes
This educational program is conceived and credited in accordance with ACCME's Essential Areas and Policies, including the 2004 Updated Standards for Commercial Support. Pri-Med faculty hail from a variety of institutions and participate in content development, along with pmiCME's Advisory Boards and its expert review partners, the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute. All final decisions about program content are the responsibility of pmiCME.
||AMA PRA Category 1 Credits
||pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
||pmiCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Faculty and Editorial Board
James R. Gavin III, MD, PhD, (Read Bio), CEO and Chief Medical Officer, Healing Our Village, Inc., Clinical Professor of Medicine, Emory University School of Medicine, Atlanta, Georgia
Frank Lavernia, MD, (Read Bio), Founder and Medical Director, North Broward Diabetes Center, North Broward Medical Center, Pompano Beach, Florida
Mark W. Stolar, MD, (Read Bio), Associate Professor of Clinical Medicine, Northwestern University Medical School, Northwestern Memorial Hospital, Chicago, Illinois
Zachary Schwartz, MSc, ELS, pmiCME
Financial Disclosure Statement(s)
James R. Gavin III, MD, PhD reports the following: Speakers Bureau: AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, Novo Nordisk. Consultant: Astra-Zeneca, Daiichi Sankyo Co., Ltd., Eli Lilly and Company, sanofi-aventis. Stockholder: Amylin Pharmaceuticals, Inc.
Frank Lavernia, MD reports he is on the speakers bureau for Abbott Laboratories.
Mark W. Stolar, MD reports is he is a member of the speakers bureau and advisory board for Takeda Pharmaceuticals Inc.
Instructions for Obtaining Credit:
Complete this activity. Answer the questions in the attached posttest and evaluation. Click on "claim credit" and follow the instructions to print out the credit certificate.
Computer System Requirements:
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, pmiCME, pmiCME Advisory Boards and Consultants, or M|C Communications, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.